Comments

HOOKIPA Pharma

HOOKNASDAQ
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$6.15
-0.17-2.69%
At Close: -
$6.20
0.050.81%
After Hours: Jul 25, 4:17 PM EDT
15 minutes delayed
HOOKIPA Pharma (HOOK) ForecastNewsEarningsGuidanceDividends

Analyst Ratings

Insider TradesShort Interest
Consensus Rating1
Buy
Highest Price Target1
$23.00
Lowest Price Target1
$0.50
Consensus Price Target1
$6.47

Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Click Here

HOOKIPA Pharma (NASDAQ:HOOK) Stock, Analyst Ratings, Price Targets, Forecasts

HOOKIPA Pharma Inc has a consensus price target of $6.47 based on the ratings of 8 analysts. The high is $23 issued by JMP Securities on July 26, 2024. The low is $0.5 issued by B of A Securities on December 2, 2022. The 3 most-recent analyst ratings were released by JMP Securities, HC Wainwright & Co., and RBC Capital on July 26, 2024, June 5, 2024, and May 21, 2024, respectively. With an average price target of $11.33 between JMP Securities, HC Wainwright & Co., and RBC Capital, there's an implied 82.80% upside for HOOKIPA Pharma Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Apr
1
May
0
0
0
0
Jun
0
0
0
0
Jul
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.3
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

JMP Securities
HC Wainwright & Co.
RBC Capital
Truist Securities
Morgan Stanley

1calculated from analyst ratings

Analyst Ratings for HOOKIPA Pharma

Buy NowGet Alert
07/26/2024Buy Now270.97%JMP Securities
Jason Butler
$50 → $23MaintainsMarket OutperformGet Alert
06/05/2024Buy Now-3.23%HC Wainwright & Co.
Arthur He
$50 → $60MaintainsBuyGet Alert
05/21/2024Buy Now-19.35%RBC Capital
Brian Abrahams
$50 → $50ReiteratesOutperform → OutperformGet Alert
04/26/2024Buy Now-19.35%HC Wainwright & Co.
Arthur He
$65 → $50MaintainsBuyGet Alert
03/25/2024Buy Now-19.35%RBC Capital
Brian Abrahams
$50 → $50ReiteratesOutperform → OutperformGet Alert
03/25/2024Buy Now4.84%HC Wainwright & Co.
Arthur He
$65 → $65ReiteratesBuy → BuyGet Alert
01/30/2024Buy Now-19.35%RBC Capital
Brian Abrahams
$60 → $50MaintainsOutperformGet Alert
09/27/2023Buy Now12.9%RBC Capital
Brian Abrahams
 → $70ReiteratesOutperform → OutperformGet Alert
09/06/2023Buy Now-35.48%Truist Securities
Asthika Goonewardene
 → $40ReiteratesBuy → BuyGet Alert
08/11/2023Buy Now4.84%HC Wainwright & Co.
Arthur He
$80 → $65MaintainsBuyGet Alert
06/30/2023Buy Now12.9%RBC Capital
Brian Abrahams
 → $70ReiteratesOutperform → OutperformGet Alert
06/05/2023Buy Now-63.71%Morgan Stanley
Vikram Purohit
$20 → $22.5MaintainsEqual-WeightGet Alert
05/12/2023Buy Now29.03%HC Wainwright & Co.
Arthur He
 → $80ReiteratesBuy → BuyGet Alert
03/20/2023Buy Now-35.48%Truist Securities
Asthika Goonewardene
$110 → $40MaintainsBuyGet Alert
03/16/2023Buy Now29.03%HC Wainwright & Co.
Arthur He
 → $80Reiterates → BuyGet Alert
12/02/2022Buy Now-91.94%B of A Securities
Alec Stranahan
$60 → $5DowngradeBuy → UnderperformGet Alert
11/15/2022Buy Now12.9%RBC Capital
Brian Abrahams
$80 → $70MaintainsOutperformGet Alert
08/23/2022Buy Now77.42%Truist Securities
Asthika Goonewardene
$160 → $110MaintainsBuyGet Alert
08/11/2022Buy Now-51.61%SVB Leerink
Andrew Berens
$40 → $30MaintainsOutperformGet Alert
03/25/2022Buy Now45.16%RBC Capital
Brian Abrahams
$110 → $90MaintainsOutperformGet Alert
02/17/2022Buy Now29.03%HC Wainwright & Co.
Swayampakula Ramakanth
$150 → $80MaintainsBuyGet Alert
02/16/2022Buy Now-35.48%SVB Leerink
Andrew Berens
$30 → $40MaintainsOutperformGet Alert
11/12/2021Buy Now-3.23%Morgan Stanley
Vikram Purohit
 → $60DowngradeOverweight → Equal-WeightGet Alert
11/11/2021Buy Now141.94%HC Wainwright & Co.
Swayampakula Ramakanth
$210 → $150MaintainsBuyGet Alert
11/10/2021Buy Now61.29%SVB Leerink
Andrew Berens
$280 → $100MaintainsOutperformGet Alert
11/10/2021Buy Now174.19%RBC Capital
Brian Abrahams
$240 → $170MaintainsOutperformGet Alert
11/10/2021Buy Now77.42%JMP Securities
Jason Butler
$250 → $110MaintainsMarket OutperformGet Alert
08/18/2021Buy Now190.32%Morgan Stanley
Vikram Purohit
$190 → $180MaintainsOverweightGet Alert

FAQ

Q

What is the target price for HOOKIPA Pharma (HOOK) stock?

A

The latest price target for HOOKIPA Pharma (NASDAQ:HOOK) was reported by JMP Securities on July 26, 2024. The analyst firm set a price target for $23.00 expecting HOOK to rise to within 12 months (a possible 270.97% upside). 10 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for HOOKIPA Pharma (HOOK)?

A

The latest analyst rating for HOOKIPA Pharma (NASDAQ:HOOK) was provided by JMP Securities, and HOOKIPA Pharma maintained their market outperform rating.

Q

When was the last upgrade for HOOKIPA Pharma (HOOK)?

A

There is no last upgrade for HOOKIPA Pharma

Q

When was the last downgrade for HOOKIPA Pharma (HOOK)?

A

The last downgrade for HOOKIPA Pharma Inc happened on December 2, 2022 when B of A Securities changed their price target from $6 to $0.5 for HOOKIPA Pharma Inc.

Q

When is the next analyst rating going to be posted or updated for HOOKIPA Pharma (HOOK)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of HOOKIPA Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for HOOKIPA Pharma was filed on July 26, 2024 so you should expect the next rating to be made available sometime around July 26, 2025.

Q

Is the Analyst Rating HOOKIPA Pharma (HOOK) correct?

A

While ratings are subjective and will change, the latest HOOKIPA Pharma (HOOK) rating was a maintained with a price target of $50.00 to $23.00. The current price HOOKIPA Pharma (HOOK) is trading at is $6.20, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch